Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding trial of CKBA ointment in non-segmental vitiligo
CTR20233352Phase 2Active
- Sponsor
- Bochuangyuan Biopharmaceutical
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 3-O-cyclohexanecarbonyl-11-keto-β-boswellic acid in Vitiligo, sponsored by Bochuangyuan Biopharmaceutical. Started Nov 2023; status: active.
02
Drugs
3-O-cyclohexanecarbonyl-11-keto-β-boswellic acid
03
Conditions
Vitiligo
Beyond the preview
Go deeper on CTR20233352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233352.